“Anticancer Effects of Combined γ-Tocotrienol and PPARγ-Antagonist Treatment are Associated with a Suppression in Adipogenic Factor Expression”, J. Pharm. Nutr. Sci., vol. 4, no. 1, pp. 43–56, Jan. 2014, doi: 10.6000/1927-5951.2014.04.01.7.